F
10b5-1 Plan
$ Value
$65K
Shares
267
Price
$245
Filed
Jun 3
Insider
Name
Rider Michael J
Title
Global General Counsel
CIK
0001982205
Roles
Officer
Transaction Details
Transaction Date
2025-06-02
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
8,603
Footnotes
The transaction was conducted under a Rule 10b5-1 plan adopted February 28, 2025. | Includes 64.6438 shares of ResMed stock purchased on April 30, 2025, through the ResMed Employee Stock Purchase Plan. | Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 06/01/2023.
Filing Info
Rider Michael J's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-02 | RMD | ▼ | $12K |
| 2025-12-01 | RMD | ▼ | $12K |
| 2025-11-11 | RMD | F | $34K |
| 2025-11-11 | RMD | F | $43K |
| 2025-11-11 | RMD | F | $179K |
| 2025-11-11 | RMD | F | $125K |
| 2025-10-01 | RMD | ▼ | $27K |
| 2025-08-15 | RMD | A | $0 |
| 2025-08-01 | RMD | ▼ | $14K |
| 2025-07-01 | RMD | ▼ | $17K |
Other Insiders at RMD (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| FARRELL PETER C | — | $450K | 2026-04-01 |
|
Sandercock Brett
Chief Financial Officer
|
— | $224K | 2026-04-01 |
|
Farrell Michael J.
Chairman and CEO
|
— | $1.1M | 2026-04-07 |